129 related articles for article (PubMed ID: 25513779)
1. In-vivo longitudinal MRI study: an assessment of melanoma brain metastases in a clinically relevant mouse model.
Henry MN; Chen Y; McFadden CD; Simedrea FC; Foster PJ
Melanoma Res; 2015 Apr; 25(2):127-37. PubMed ID: 25513779
[TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach.
Percy DB; Ribot EJ; Chen Y; McFadden C; Simedrea C; Steeg PS; Chambers AF; Foster PJ
Invest Radiol; 2011 Nov; 46(11):718-25. PubMed ID: 21788908
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI.
Leenders W; Küsters B; Pikkemaat J; Wesseling P; Ruiter D; Heerschap A; Barentsz J; de Waal RM
Int J Cancer; 2003 Jul; 105(4):437-43. PubMed ID: 12712432
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
6. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
[TBL] [Abstract][Full Text] [Related]
7. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
Isiklar I; Leeds NE; Fuller GN; Kumar AJ
AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
[TBL] [Abstract][Full Text] [Related]
8. Novel human melanoma brain metastasis models in athymic nude fox1
Svendsen HA; Meling TR; Nygaard V; Waagene S; Russnes H; Juell S; Rogne SG; Pahnke J; Helseth E; Fodstad Ø; Maelandsmo GM
Cancer Med; 2021 Dec; 10(23):8604-8613. PubMed ID: 34612023
[TBL] [Abstract][Full Text] [Related]
9. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous assessment of vessel size index, relative blood volume, and vessel permeability in a mouse brain tumor model using a combined spin echo gradient echo echo-planar imaging sequence and viable tumor analysis.
Kording F; Weidensteiner C; Zwick S; Osterberg N; Weyerbrock A; Staszewski O; von Elverfeldt D; Reichardt W
J Magn Reson Imaging; 2014 Dec; 40(6):1310-8. PubMed ID: 24390982
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
[TBL] [Abstract][Full Text] [Related]
12. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
13. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors.
Sijens PE; Levendag PC; Vecht CJ; van Dijk P; Oudkerk M
NMR Biomed; 1996 Apr; 9(2):65-71. PubMed ID: 8887370
[TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
Golfieri R; Cherryman GR; Olliff JF; Husband JE
Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
Takeda T; Takeda A; Nagaoka T; Kunieda E; Takemasa K; Watanabe M; Hatou T; Oguro S; Katayama M
Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Wang QJ; Wang Y; Xu X; Xiao H; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
[TBL] [Abstract][Full Text] [Related]
17. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging.
Tomura N; Narita K; Takahashi S; Otani T; Sakuma I; Yasuda K; Nishii T; Watarai J
Acta Radiol; 2007 Nov; 48(9):1032-7. PubMed ID: 17957522
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
20. [Gd-DTPA in the diagnosis of brain metastasis].
Kornienko VN; Pronin IN
Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
